Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published Date:

Abstract

Hepatocellular carcinoma (HCC) is a representative primary liver cancer caused by long-term and repetitive liver injury. Surgical resection is generally selected as the radical cure treatment. Because the early recurrence of HCC after resection is associated with low overall survival, the prediction of recurrence after resection is clinically important. However, the pathological characteristics of the early recurrence of HCC have not yet been elucidated. We attempted to predict the early recurrence of HCC after resection based on digital pathologic images of hematoxylin and eosin-stained specimens and machine learning applying a support vector machine (SVM). The 158 HCC patients meeting the Milan criteria who underwent surgical resection were included in this study. The patients were categorized into three groups: Group I, patients with HCC recurrence within 1 year after resection (16 for training and 23 for test); Group II, patients with HCC recurrence between 1 and 2 years after resection (22 and 28); and Group III, patients with no HCC recurrence within 4 years after resection (31 and 38). The SVM-based prediction method separated the three groups with 89.9% (80/89) accuracy. Prediction of Groups I was consistent for all cases, while Group II was predicted to be Group III in one case, and Group III was predicted to be Group II in 8 cases. The use of digital pathology and machine learning could be used for highly accurate prediction of HCC recurrence after surgical resection, especially that for early recurrence. Currently, in most cases after HCC resection, regular blood tests and diagnostic imaging are used for follow-up observation; however, the use of digital pathology coupled with machine learning offers potential as a method for objective postoprative follow-up observation.

Authors

  • Akira Saito
    Division of Life Science and Engineering, School of Science and Engineering, Tokyo Denki University (TDU), Ishizaka, Hatoyama-Machi, Hiki-Gun, Saitama, 350-0394, Japan.
  • Hidenori Toyoda
    Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Gifu, 503-0864, Japan.
  • Masaharu Kobayashi
    Chi Corporation, Shinjuku-ku, Tokyo, 101-0042, Japan.
  • Yoshinori Koiwa
    Chi Corporation, Shinjuku-ku, Tokyo, 101-0042, Japan.
  • Hiroki Fujii
    Chi Corporation, Shinjuku-ku, Tokyo, 101-0042, Japan.
  • Koji Fujita
    Department of Molecular Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo, 160-8402, Japan.
  • Atsuyuki Maeda
    Department of Surgery, Ogaki Municipal Hospital, Ogaki Gifu, 503-0864, Japan.
  • Yuji Kaneoka
    Department of Surgery, Ogaki Municipal Hospital, Ogaki Gifu, 503-0864, Japan.
  • Shoichi Hazama
  • Hiroaki Nagano
  • Aashiq H Mirza
    Department of Pharmacology, Weill Cornell Medicine, New York, New York.
  • Hans-Peter Graf
    Department of Machine Learning, NEC Labs America Inc., Princeton, NJ, 08540, USA.
  • Eric Cosatto
    Department of Machine Learning, NEC Laboratories America, NJ, USA.
  • Yoshiki Murakami
    Department of Molecular Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo, 160-8402, Japan. yoshikim@tokyo-med.ac.jp.
  • Masahiko Kuroda